Annette Bakker, PhD, President and Chief Scientific Officer, of the Children’s Tumor Foundation (CTF) discusses her Foundation’s partnership with SpringWorks Therapeutics. SpingWorks is working with CTF on treatments for Neurofibromatosis.
By: Peter Ciszewski| Published on: Jan 22, 2018
Annette Bakker, PhD, President and Chief Scientific Officer, of the Children’s Tumor Foundation (CTF) discusses her Foundation’s partnership with SpringWorks Therapeutics. SpingWorks is working with CTF on treatments for Neurofibromatosis.
| Cookie | Duration | Description |
|---|---|---|
| cookielawinfo-checkbox-analytics | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics". |
| cookielawinfo-checkbox-functional | 11 months | The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional". |
| cookielawinfo-checkbox-necessary | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary". |
| cookielawinfo-checkbox-others | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other. |
| cookielawinfo-checkbox-performance | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance". |
| viewed_cookie_policy | 11 months | The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data. |